BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20559706)

  • 21. Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.
    Ricardo S; Marcos-Silva L; Valente C; Coelho R; Gomes R; David L
    Virchows Arch; 2016 Jun; 468(6):715-22. PubMed ID: 27003157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guided therapy.
    Chauhan SC; Vinayek N; Maher DM; Bell MC; Dunham KA; Koch MD; Lio Y; Jaggi M
    J Histochem Cytochem; 2007 Aug; 55(8):867-75. PubMed ID: 17478446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
    Togami S; Nomoto M; Higashi M; Goto M; Yonezawa S; Tsuji T; Batra SK; Douchi T
    J Obstet Gynaecol Res; 2010 Jun; 36(3):588-97. PubMed ID: 20598042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mumps epidemic on St. George Island, Alaska.
    Reed D; Brown G; Merrick R; Sever J; Feltz E
    JAMA; 1967 Mar; 199(13):113-7. PubMed ID: 4164273
    [No Abstract]   [Full Text] [Related]  

  • 25. MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells.
    Gubbels JA; Felder M; Horibata S; Belisle JA; Kapur A; Holden H; Petrie S; Migneault M; Rancourt C; Connor JP; Patankar MS
    Mol Cancer; 2010 Jan; 9():11. PubMed ID: 20089172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resurgence of mumps in Singapore caused by the Rubini mumps virus vaccine strain.
    Goh KT
    Lancet; 1999 Oct; 354(9187):1355-6. PubMed ID: 10533868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of vaccine-induced and naturally acquired class-specific mumps antibodies by two indirect enzyme-linked immunosorbent assays.
    Nigro G; Nanni F; Midulla M
    J Virol Methods; 1986 May; 13(2):91-106. PubMed ID: 3016017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site.
    Wright SE; Kilinski L; Talib S; Lowe KE; Burnside JS; Wu JY; Dolby N; Dombrowski KE; Lebkowski JS; Philip R
    J Immunother; 2000 Jan; 23(1):2-10. PubMed ID: 10687132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MUC1 in endometriosis and ovarian cancer.
    Vlad AM; Diaconu I; Gantt KR
    Immunol Res; 2006; 36(1-3):229-36. PubMed ID: 17337783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue and serum MUC1 mucin detection in breast cancer patients.
    Croce MV; Isla-Larrain MT; Demichelis SO; Gori JR; Price MR; Segal-Eiras A
    Breast Cancer Res Treat; 2003 Oct; 81(3):195-207. PubMed ID: 14620915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The results of an immunoepidemiological examination of foci of epidemic parotitis].
    Bolotovskiĭ VM; Gelikman BG; Mikheeva IV; Shubin NS; Glinskaia EV
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Aug; (8):42-6. PubMed ID: 2239003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies against mumps in The Netherlands as assessed by indirect ELISA and virus neutralization assay.
    van den Hof S; Beaumont MT; Berbers GA; de Melker HE
    Epidemiol Infect; 2003 Aug; 131(1):703-9. PubMed ID: 12948370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
    Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R
    Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating anti-MUC1 IgG antibodies as a favorable prognostic factor for pancreatic cancer.
    Hamanaka Y; Suehiro Y; Fukui M; Shikichi K; Imai K; Hinoda Y
    Int J Cancer; 2003 Jan; 103(1):97-100. PubMed ID: 12455059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of autoantibody spectrum against ovarian cancer associated antigens combined with CA(125) in detecting and monitoring ovarian cancer].
    Yang ZJ; Yang G; Jiang YM; Ran YL; Yang ZH; Zhang W; Zhang JQ; Pan ZM; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):113-8. PubMed ID: 21426769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles and mumps immunity in Northern Greece, 2004-2007.
    Fylaktou A; Haidopoulou K; Goutaki M; Papadimitriou E; Kalamitsiou S; Papaventsis D
    Euro Surveill; 2008 Apr; 13(16):. PubMed ID: 18768118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
    Feng H; Ghazizadeh M; Konishi H; Araki T
    Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible role of mumps virus in the etiology of ovarian cancer.
    Menczer J; Modan M; Ranon L; Golan A
    Cancer; 1979 Apr; 43(4):1375-9. PubMed ID: 445337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum markers CASA and CA 15-3 in ovarian cancer: all MUC1 assays are not the same.
    Devine PL; McGuckin MA; Quin RJ; Ward BG
    Tumour Biol; 1994; 15(6):337-44. PubMed ID: 7997805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.